• Menveo is indicated for active immunization of children (from 2 years of
age), adolescents and adults at risk of exposure to Neisseria meningitidis
groups A, C, W135 and Y, to prevent invasive disease.
• The use of this
vaccine should be in accordance with official recommendations.
Signup to K2
Register today for a Kays Medical trade account and begin using K2 to place orders securely and conveniently for immediate delivery.
Click here to signup or if already registered click here to login.